| 000 | 01473 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517082112.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1590-3729 | ||
| 024 | 7 |
_a10.1016/j.numecd.2016.02.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaroni, M G | |
| 245 | 0 | 0 |
_aItalian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly. _h[electronic resource] |
| 260 |
_bNutrition, metabolism, and cardiovascular diseases : NMCD _cFeb 2016 |
||
| 300 |
_a85-102 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline; Review; Systematic Review | ||
| 650 | 0 | 4 |
_aAcromegaly _xcomplications |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 |
_aCushing Syndrome _xcomplications |
| 650 | 0 | 4 |
_aEndocrinology _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xblood |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aSocieties, Medical |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGiorgino, F | |
| 700 | 1 | _aPezzino, V | |
| 700 | 1 | _aScaroni, C | |
| 700 | 1 | _aAvogaro, A | |
| 773 | 0 |
_tNutrition, metabolism, and cardiovascular diseases : NMCD _gvol. 26 _gno. 2 _gp. 85-102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.numecd.2016.02.001 _zAvailable from publisher's website |
| 999 |
_c25760518 _d25760518 |
||